Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

25.03.2024

2 Am J Respir Crit Care Med
3 Ann Allergy Asthma Immunol
1 Can Respir J
2 Clin Exp Allergy
1 Curr Opin Pulm Med
1 Eur Respir J
1 J Allergy Clin Immunol
2 J Asthma
1 Pediatr Allergy Immunol
2 Pediatr Pulmonol
2 PLoS One
1 Pneumologie
5 Respir Med
2 Respir Res
5 Thorax



    Am J Respir Crit Care Med

  1. XIAN G, Long Z, Wang Y
    Asthma-Chronic Obstructive Pulmonary Disease Overlap versus Chronic Obstructive Pulmonary Disease: Comparing Apples and Oranges.
    Am J Respir Crit Care Med. 2024;209:765-766.
    >> Share

  2. GERSTEIN E, Bierbrier J, Whitmore GA, Aaron SD, et al
    Reply to: Asthma-Chronic Obstructive Pulmonary Disease Overlap versus Chronic Obstructive Pulmonary Disease: Comparing Apples and Oranges.
    Am J Respir Crit Care Med. 2024;209:766-767.
    >> Share


    Ann Allergy Asthma Immunol

  3. HUANG D, Zhang L, Liu Y, Wang J, et al
    Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
    >> Share

  4. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
    Evidence for two clusters among non-eosinophilic asthmatics.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
    >> Share

  5. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
    Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
    >> Share


    Can Respir J

  6. CHEN Z, Zha L, Hu B, Xu B, et al
    Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Can Respir J. 2024;2024:6038771.
    >> Share


    Clin Exp Allergy

  7. WILLIAMS I, Daniel J, Mansur AH, Christopher DJ, et al
    Exploring facilitators and barriers in asthma management in rural, semi-urban and urban populations in Vellore, India: An interview study of patients and primary care physicians.
    Clin Exp Allergy. 2024 Mar 18. doi: 10.1111/cea.14477.
    >> Share

  8. HUSSAIN H, McKeever TM, Gonem S
    Asthma outcomes, inhaled corticosteroid adherence and socio-economic deprivation in English regions.
    Clin Exp Allergy. 2024 Mar 17. doi: 10.1111/cea.14474.
    >> Share


    Curr Opin Pulm Med

  9. KHURANA S, Taube C
    Editorial: The evolving landscape of asthma: recent advances and challenges.
    Curr Opin Pulm Med. 2024;30:266-267.
    >> Share


    Eur Respir J

  10. LIU T, Liu S, Rui X, Cao Y, et al
    Gasdermin B, an asthma-susceptibility gene, promotes MAVS-TBK1 signaling and airway inflammation.
    Eur Respir J. 2024 Mar 21:2301232. doi: 10.1183/13993003.01232-2023.
    >> Share


    J Allergy Clin Immunol

  11. GOMEZ HM, Haw TJ, Ilic D, Robinson P, et al
    Landscape fire smoke airway exposure impairs respiratory and cardiac function and worsens experimental asthma.
    J Allergy Clin Immunol. 2024 Mar 19:S0091-6749(24)00272.
    >> Share


    J Asthma

  12. ZEWDIE S, Bayked EM, Ayenew W, Seyfu A, et al
    Prevalence and Predictors of Medication Adherence among Adolescents and Adults with Asthma in Ethiopia: Systematic review and meta-analysis.
    J Asthma. 2024 Mar 21:1-17. doi: 10.1080/02770903.2024.2332920.
    >> Share

  13. ALYAMI MM, Alasimi AH, Alqarni AA, Balharith FH, et al
    Prevalence of Asthma Triggers and Control Status Among Pediatric Asthmatic Patients in Saudi Arabia.
    J Asthma. 2024 Mar 20:1-10. doi: 10.1080/02770903.2024.2332917.
    >> Share


    Pediatr Allergy Immunol

  14. WEDNER HJ, Fujisawa T, Guilbert TW, Ikeda M, et al
    Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study).
    Pediatr Allergy Immunol. 2024;35:e14092.
    >> Share


    Pediatr Pulmonol

  15. YANG S, He X, Zhang R
    Clinical efficacy of montelukast sodium combination therapy for cough variant asthma in children: A meta-analysis.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26960.
    >> Share

  16. SHANTHIKUMAR S, Homaira N, Montgomery B, Hiscock H, et al
    The current state of pediatric asthma in Australia.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26978.
    >> Share


    PLoS One

  17. NARTENI S, Baiardini I, Braido F, Mongelli M, et al
    Explainable artificial intelligence for cough-related quality of life impairment prediction in asthmatic patients.
    PLoS One. 2024;19:e0292980.
    >> Share

  18. LIU WY, Spruit MA, Delbressine JM, Willems PJ, et al
    Alterations in stride-to-stride fluctuations in patients with chronic obstructive pulmonary disease during a self-paced treadmill 6-minute walk test.
    PLoS One. 2024;19:e0300592.
    >> Share


    Pneumologie

  19. LOMMATZSCH M, Criee CP, de Jong CCM, Gappa M, et al
    [Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.].
    Pneumologie. 2023;77:e3.
    >> Share


    Respir Med

  20. JEONG J, Nam YH, Sim DW, Kim BK, et al
    Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
    Respir Med. 2024;225:107598.
    >> Share

  21. FARKAS A, Horvath A, Reti I, Ilyes N, et al
    Comparative study of the inhalation parameters of COPD patients through NEXThaler(R) and Ellipta(R) dry powder inhalers.
    Respir Med. 2024;224:107576.
    >> Share

  22. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
    The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
    Respir Med. 2024;224:107564.
    >> Share

  23. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
    Predicting exacerbations in COPD in the Danish general population.
    Respir Med. 2024;224:107557.
    >> Share

  24. BROCKWAY K, Ahmed S
    Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.
    Respir Med. 2024;224:107553.
    >> Share


    Respir Res

  25. SHIN SH, Kim T, Kim H, Cho J, et al
    Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study.
    Respir Res. 2024;25:133.
    >> Share

  26. MEI S, Li D, Wang A, Zhu G, et al
    The role of sialidase Neu1 in respiratory diseases.
    Respir Res. 2024;25:134.
    >> Share


    Thorax

  27. PETOUSI N, Pavord ID, Kent BD
    Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
    Thorax. 2024;79:291-292.
    >> Share

  28. CELIS-PRECIADO CA, Lachapelle P, Couillard S
    Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.
    Thorax. 2024;79:297-298.
    >> Share

  29. VOGIATZIS I
    Role of blood flow restriction strength training in chronic obstructive pulmonary disease.
    Thorax. 2024;79:289-290.
    >> Share

  30. COLAK Y, Afzal S, Marott JL, Vestbo J, et al
    Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Thorax. 2024;79:349-358.
    >> Share

  31. KOHLBRENNER D, Kuhn M, Manettas A, Aregger C, et al
    Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.
    Thorax. 2024;79:340-348.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016